Rhythm Pharmaceuticals In... (RYTM)
NASDAQ: RYTM
· Real-Time Price · USD
97.69
1.21 (1.25%)
At close: Aug 15, 2025, 3:59 PM
97.50
-0.19%
After-hours: Aug 15, 2025, 06:27 PM EDT
Rhythm Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 156.29M | 136.86M | 130.13M | 112.53M | 101.78M | 91.93M | 77.43M | 61.98M | 43.76M | 33.61M | 23.64M | 16.66M | 13.41M | 4.62M | 3.15M | 1.34M | 309K | 35K |
Cost of Revenue | 16.81M | 14.39M | 13.74M | 13.18M | 11.77M | 10.88M | 9.3M | 7.1M | 5.18M | 3.32M | 2.13M | 1.34M | 1.07M | 825K | 599K | 363K | 141K | 4K |
Gross Profit | 139.48M | 122.48M | 116.39M | 99.35M | 90.02M | 81.05M | 68.13M | 54.89M | 38.58M | 30.29M | 21.5M | 15.32M | 12.34M | 3.79M | 2.56M | 974K | 168K | 31K |
Operating Income | -177.44M | -172.62M | -265.5M | -265.51M | -265.58M | -271.71M | -184.35M | -185.19M | -180.5M | -179M | -179.16M | -188.04M | -193.02M | -188.35M | -170.06M | -154.14M | -144.19M | -135.67M |
Interest Income | 14.45M | 15.3M | 14.71M | 15.02M | 14.43M | 13.55M | 13.95M | 13.17M | 10.62M | 7.67M | 4.39M | 1.49M | 706K | 453K | 447K | 489K | 817K | 1.6M |
Pretax Income | -183.08M | -168.57M | -260.22M | -258.28M | -258.09M | -273.01M | -184.11M | -185.17M | -182.24M | -180.53M | -181.12M | -189.48M | -192.72M | -188.13M | -69.61M | -53.65M | -43.37M | -34.08M |
Net Income | -183.06M | -168.69M | -260.57M | -258.91M | -259.43M | -273.87M | -184.33M | -185.19M | -183.48M | -181.78M | -182.79M | -183.16M | -175.81M | -166.2M | -69.61M | -61.64M | -60.35M | -56.08M |
Selling & General & Admin | 158.54M | 149.01M | 144.3M | 138.55M | 133.65M | 127.28M | 117.53M | 111.47M | 102.94M | 95.22M | 92.03M | 86.71M | 82.28M | 75.42M | 68.49M | 60.61M | 54.39M | 47.85M |
Research & Development | 158.38M | 146.09M | 237.59M | 226.31M | 221.95M | 225.48M | 134.95M | 128.61M | 116.15M | 114.06M | 108.63M | 116.66M | 123.08M | 116.73M | 104.13M | 94.51M | 89.96M | 87.86M |
Other Expenses | n/a | 302K | 826K | 1.39M | 1.23M | 907K | 356K | -203K | -414K | -530K | -736K | -736K | -366K | -233K | n/a | n/a | n/a | n/a |
Operating Expenses | 316.92M | 295.1M | 381.89M | 364.86M | 355.6M | 352.76M | 252.48M | 240.08M | 219.09M | 209.28M | 200.66M | 203.37M | 205.36M | 192.15M | 172.62M | 155.12M | 144.35M | 135.7M |
Interest Expense | 21.91M | 20.7M | 20.05M | 19.15M | 17.06M | 15.76M | 14.06M | 12.52M | 11.52M | 8.26M | 5.2M | 2.19M | 46K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 323K | 323K | 323K |
Cost & Expenses | 333.73M | 309.48M | 395.63M | 378.05M | 367.37M | 363.63M | 261.78M | 247.18M | 224.27M | 212.61M | 202.79M | 204.71M | 206.43M | 192.97M | 173.21M | 155.48M | 144.5M | 135.71M |
Income Tax Expense | -17K | 125K | 345K | 631K | 1.34M | 946K | 294K | 98K | 1.32M | 1.16M | 1.58M | -6.41M | -17M | -21.93M | n/a | 7.81M | 16.63M | 21.48M |
Shares Outstanding (Basic) | 63.68M | 63.06M | 61.6M | 61.22M | 61.01M | 60.14M | 59.21M | 57.87M | 56.87M | 56.71M | 56.3M | 51.4M | 50.4M | 50.25M | 50.27M | 50.25M | 50.21M | 47.64M |
Shares Outstanding (Diluted) | 63.68M | 63.06M | 61.6M | 61.22M | 61.01M | 60.14M | 59.21M | 57.87M | 56.87M | 56.71M | 56.3M | 51.4M | 50.4M | 50.33M | 50.27M | 50.25M | 50.21M | 48.5M |
EPS (Basic) | -2.99 | -2.77 | -4.31 | -4.29 | -4.34 | -4.63 | -3.19 | -3.24 | -3.31 | -3.38 | -3.52 | -3.62 | -3.49 | -3.3 | -1.33 | -1.27 | -1.34 | -1.35 |
EPS (Diluted) | -2.99 | -2.77 | -4.31 | -4.29 | -4.34 | -4.63 | -3.19 | -3.24 | -3.31 | -3.38 | -3.52 | -3.62 | -3.49 | -3.3 | -1.35 | -1.29 | -1.36 | -1.37 |
EBITDA | -163.01M | -149.7M | -238.61M | -238.05M | -239.79M | -255.86M | -168.52M | -170.57M | -168.81M | -170.58M | -174.42M | -186.04M | -191.49M | -186.97M | -168.76M | -152.99M | -143.32M | -134.95M |
EBIT | -161.17M | -147.87M | -240.18M | -239.13M | -241.03M | -257.25M | -170.05M | -172.65M | -170.72M | -172.27M | -175.84M | -187.35M | -192.74M | -188.21M | -169.92M | -154M | -144.19M | -135.67M |
Depreciation & Amortization | 1.53M | 1.54M | 1.56M | 1.6M | 1.76M | 1.91M | 2.05M | 2.08M | 1.91M | 1.74M | 1.47M | 1.36M | 1.3M | 1.24M | 1.16M | 1.01M | 868K | 724K |